Search PubMed⌕ Search

Biomedical subjects

R E Olson

Publications and source records attributed to R E Olson.

At least 19 recordsLinked to original sources

Extreme sensitivity of differential momentum transfer cross sections to target atom initial conditions.

Heavy-particle cross sections differential in the momentum transferred to the target are investigated using the classical trajectory Monte Carlo method. With the 3.6 MeV/mu Au(53+) + He system as a test case, it is shown that these cross sections are extremely sensitive to the initial target temperature. In particular, when thermal motion is varied for one of the target's initial momentum components between 0 and 25 K the absolute cross sections vary by orders of magnitude and, in addition, their relative shapes undergo major changes. We find that by setting one of the target's transverse momenta to a temperature of 16 K, previously reported major discrepancies between theory and experiment are removed.

Journal Article↗

Preheat effects on shock propagation in indirect-drive inertial confinement fusion ablator materials.

The velocities and temperatures of shock waves generated by laser-driven hohlraum radiation fields have been measured for several indirect-drive inertial confinement fusion capsule ablator materials. For the first time, a time-resolved measurement of the preheat temperature ahead of the shock front has been performed and included in the analysis. It is found that preheat ahead of the shock front can cause significant shock propagation variations in the ignition capsule ablator materials being considered for the National Ignition Facility (NIF). If unaccounted for, these preheat effects could potentially preclude ignition at the NIF.

Journal Article↗

Laboratory simulation of charge exchange-produced X-ray emission from comets.

In laboratory experiments using the engineering spare microcalorimeter detector from the ASTRO-E satellite mission, we recorded the x-ray emission of highly charged ions of carbon, nitrogen, and oxygen, which simulates charge exchange reactions between heavy ions in the solar wind and neutral gases in cometary comae. The spectra are complex and do not readily match predictions. We developed a charge exchange emission model that successfully reproduces the soft x-ray spectrum of comet Linear C/1999 S4, observed with the Chandra X-ray Observatory.

Journal Article↗

Simultaneous projectile-target ionization: a novel approach to (e, 2e) experiments on ions.

A kinematically complete experiment for simultaneous ionization of a projectile and target has been performed for 3.6 MeV/u C2+ on He collisions measuring the final vector momenta of the He1+ recoil ion and of two electrons (projectile, target) in coincidence with the emerging C3+ projectile. The feasibility of an event-by-event separation of the various reaction channels, among them the ionization of C2+ by the interaction with a quasifree target electron, is demonstrated in agreement with six-body classical trajectory Monte Carlo calculations, paving the way to kinematically complete electron-ion scattering experiments.

Journal Article↗

Recoil momentum spectroscopy of highly charged ion collisions on magneto-optically trapped Na.

We have used a cold ( T<<1 mK), laser-cooled target of Na atoms confined in a magneto-optical trap to study electron capture processes during highly charged ion-sodium atom collisions at keV energies. Momentum distributions of target ions were determined by employing time-of-flight and position sensitive detection of the Na ions, produced during the collisions and extracted by a weak electric field. In this way impact parameter sensitive information about multielectron capture processes is obtained.

Journal Article↗

Synthesis and pharmacology of modified amidine isoxazoline glycoprotein IIb/IIIa receptor antagonists.

Selective antagonism of the platelet GPIIb/IIIa receptor represents an attractive mechanism for the prevention and treatment of a number of thrombotic disease states. The antiplatelet activity of the oral GPIIb/IIIa receptor antagonists DMP 754 and DMP 802 have been disclosed. In this paper, the synthesis and biological evaluation of a series of potent N-substituted benzamidine isoxazolines are explored. The effect of benzamidine substitution on the duration of antiplatelet efficacy in dog is presented.

Amino Acids↗

Analytic models of high-temperature hohlraums.

A unified set of high-temperature-hohlraum models has been developed. For a simple hohlraum, P(S)=[A(S)+(1-alpha(W))A(W)+A(H)]sigmaT(4)(R)+(4Vsigma/c)(dT(4)(R)/dt), where P(S) is the total power radiated by the source, A(S) is the source area, A(W) is the area of the cavity wall excluding the source and holes in the wall, A(H) is the area of the holes, sigma is the Stefan-Boltzmann constant, T(R) is the radiation brightness temperature, V is the hohlraum volume, and c is the speed of light. The wall albedo alpha(W) identical with(T(W)/T(R))(4) where T(W) is the brightness temperature of area A(W). The net power radiated by the source P(N)=P(S)-A(S)sigmaT(4)(R), which suggests that for laser-driven hohlraums the conversion efficiency eta(CE) be defined as P(N)/P(Laser). The characteristic time required to change T(4)(R) in response to a change in P(N) is 4V/c[(1-alpha(W))A(W)+A(H)]. Using this model, T(R), alpha(W), and eta(CE) can be expressed in terms of quantities directly measurable in a hohlraum experiment. For a steady-state hohlraum that encloses a convex capsule, P(N)=[(1-alpha(W))A(W)+A(H)+[(1-alpha(C))A(C)(A(S)+alpha(W)A(W))/A(T)]]sigmaT(4)(RC), where alpha(C) is the capsule albedo, A(C) is the capsule area, A(T) identical with(A(S)+A(W)+A(H)), and T(RC) is the brightness temperature of the radiation that drives the capsule. According to this relation, the capsule-coupling efficiency of the baseline National Ignition Facility hohlraum is 15-23 % higher than predicted by previous analytic expressions. A model of a hohlraum that encloses a z pinch is also presented.

Journal Article↗

Adjectival descriptions of personality disorders: a convergent validity study of the MCMI-III.

The responses to a 469-item list of adjectives (consensually validated by national experts as representing key descriptors for each personality disorder) from 202 male substance abusers in outpatient treatment were correlated with their responses to the MCMI-III, a frequently used test for the assessment of personality disorders. Results suggested good convergent validity for the interpersonal descriptive domain for the MCMI-III scales. The Histrionic scale had extremely high convergent validity.

Adult↗

Progress towards testing the amyloid hypothesis: inhibitors of APP processing.

Alzheimer's disease is the most common form of dementia and a major public health problem. The amyloid hypothesis suggests that Alzheimer's disease is due to the abnormal accumulation of amyloid-beta protein (A beta) in affected brain regions. Rational therapies aimed at reducing amyloid burden in brain are currently being pursued in preclinical and early clinical development. This review summarizes recent progress in understanding the beta- and gamma-secretase activities required for the formation of A beta peptide and discusses therapeutic strategies aimed at inhibiting these activities. Recent progress in the identification of small molecule inhibitors of these secretases is also reviewed.

Amyloid beta-Protein Precursor↗

Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors.

Presenilins are integral membrane protein involved in the production of amyloid beta-protein. Mutations of the presenilin-1 and -2 gene are associated with familial Alzheimer's disease and are thought to alter gamma-secretase cleavage of the beta-amyloid precursor protein, leading to increased production of longer and more amyloidogenic forms of A beta, the 4-kDa beta-peptide. Here, we show that radiolabeled gamma-secretase inhibitors bind to mammalian cell membranes, and a benzophenone analog specifically photocross-links three major membrane polypeptides. A positive correlation is observed among these compounds for inhibition of cellular A beta formation, inhibition of membrane binding and cross-linking. Immunological techniques establish N- and C-terminal fragments of presenilin-1 as specifically cross-linked polypeptides. Furthermore, binding of gamma-secretase inhibitors to embryonic membranes derived from presenilin-1 knockout embryos is reduced in a gene dose-dependent manner. In addition, C-terminal fragments of presenilin-2 are specifically cross-linked. Taken together, these results indicate that potent and selective gamma-secretase inhibitors block A beta formation by binding to presenilin-1 and -2.

Amyloid Precursor Protein Secretases↗

Ring constrained analogues of beta-alanine-containing GPIIb/IIIa receptor antagonists.

A series of ring constrained analogues of the GPIIb/IIIa receptor antagonist XR299 (1) was investigated as potential inhibitors of glycoprotein IIb/IIIa, a platelet receptor that plays a key role in platelet aggregation and platelet adhesion. Ring size was found to have a large effect on in vitro potency. Selected compounds showed good in vitro activity, a preference for binding to activated platelets, and modest duration of action when dosed i.v. as a racemate in a canine model.

Humans↗

Crystalline versus amorphous content of lumaxistrade mark analog XP280 using X-ray and electron diffraction methods.

In the course of the development of Lumaxistrade mark (roxifiban), the physical state of XP280 (the besylate salt of the active metabolites of roxifiban) and SC887 (the mesylate salt of the free base of roxifiban) were characterized. Powder X-ray diffraction patterns of XP280 were ambiguous in that a high degree of background signal was present and potentially indicative of the existence of an amorphous phase. Herein the results of combined synchrotron X-ray diffraction and electron microscopy (diffraction and imaging) studies on XP280 and SC887 are reported. The combination of these two techniques allowed an unambiguous assessment of the crystallinity, as well as determination of four of the unit cell parameters of XP280 and complete determination of the unit cell parameters for SC887.

Amidines↗

Is it wise to restrict fat in the diets of children?

The proponents of fat-restricted diets for children argue that low-fat diets given in childhood will prevent the development of atherosclerosis in adulthood, low-fat diets given a childhood will condition children to prefer low-fat diets in adulthood, and low-fat diets for children are safe. There is no evidence that low-fat diets in childhood will prevent atherosclerosis in adulthood. In fact, studies of migrating populations indicate that immigrants to the United States from Third World countries who consumed low-fat diets in childhood take on the character of their new environments, including higher serum cholesterol levels and more coronary disease. The prevalence of fatty streaks in childhood bears little relationship to the prevalence of atheromatous plaques in adulthood. In fact, girls have more aortic fatty streaks and higher serum cholesterol values in childhood than boys, but fewer plaques in adulthood and less coronary disease. From the PDAY study, it has also been learned that hypercholesterolemia in childhood enhances fatty streak formation, but not that of plaques. It now seems established from autopsy studies that the progression of atherosclerosis from fatty streaks to plaque is arrested in childhood and does not begin to a significant extent until after puberty in males and after menopause in females. So the oft-repeated statement that atherosclerosis begins in childhood is semantically true but very misleading. The particularly harmful form of atherosclerosis (the plaque) does not become significant until much beyond puberty. The effects of low-fat, low-cholesterol diets on serum lipids and lipoproteins are of a lesser magnitude in children than in adults. The 0.78 mmol/L decrease in LDL cholesterol in the intervention group from controls (change 1.5%) in the DISC study was biologically insignificant and reflects the tighter control of lipoprotein and cholesterol synthesis in children compared with adults. It must be remembered that the human body synthesizes all of the cholesterol it needs from acetyl CoA. In general, the larger the amount of dietary cholesterol absorbed, the smaller the rate of biosynthesis of cholesterol. In some adults and most children this homeostatic control is nearly perfect, but in many adults the correction in biosynthesis of cholesterol with increased dietary input is imperfect and LDL cholesterol values increase. The second argument of the proponents of low-fat diets for children is that they are conditioned to continue low-fat diets in adulthood. From the studies of Birch and Fisher (51) this prediction seems unlikely. These investigators found that restricting access to palatable foods enhanced the interest of 3- to 5-year-old children in those foods and increased their desire to obtain and consume those foods. They concluded that "stringent parental controls can potentiate preference for high-fat energy-dense foods, limit children's acceptance of a variety of foods and disrupt children's regulation of energy intake." Brosin (52) has also observed that food restriction in childhood may lead to gluttony in adulthood. Finally, the claim that low-fat diets are safe in childhood is based on observations over too short a time to establish safety. It is true that growth and development of children studied in the DISC study was not changed from the expected increments, but that is not proof of long-term safety. In addition, the lower content of essential nutrients in low-fat, low-cholesterol diets (calcium, zinc, magnesium, phosphorus, vitamin E, vitamin B-12, thiamin, niacin, and riboflavin) must be considered along-term risk (53,54). Furthermore, the published studies of the safety of low-fat diets have been conducted under intensive surveillance in medical centers, conditions very different from those in the homes of free-living families.

Adolescent↗

Atherogenesis in children: implications for the prevention of atherosclerosis.

Although it is frequently stated that "atherosclerosis begins in childhood," it is not so frequently stated that only the first stage of atherosclerosis--the innocuous, highly reversible fatty streak--occurs in childhood. The more harmful second stage of atherosclerosis, the atheromatous plaque, does not appear until after puberty in boys and much later in girls. The purpose of this review is to emphasize the natural history of atherosclerosis, particularly as it pertains to children, and to consider its implications for the prevention of atherosclerosis. Present evidence supports the view that intervening in childhood (2-15 years) with low-fat, low-cholesterol diets or even worse, lipid-lowering drugs, to prevent plaque formation in adulthood is wasted effort. Furthermore, the data show that children respond more poorly to lipid-lowering diets than do adults, and that the emphasis on low-fat diets for children leads some parents to overdo the guidelines and unwittingly push their children into malnutrition. The program adopted by Health Canada on the advice of pediatricians in that country to taper fat intake from 40% of energy at 2 years of age to 30% of energy at the conclusion of linear growth (late adolescence) is a step forward.

Adult↗

Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of action.

Modification of the alpha-carbamate substituent of isoxazoline GPIIb/IIIa (alphaIIb beta3) antagonist DMP 754 (7) led to a series of alpha-sulfonamide and alpha-sulfamide diaminopropionate isoxazolinylacetamides which were found to be potent inhibitors of in vitro platelet aggregation. Aryl- and heteroaryl-alpha-sulfonamide groups, in conjunction with (5R)-isoxazoline (2S)-diaminopropionate stereochemistry, were found to impart a pronounced duration of antiplatelet effect in dogs, potentially due to high affinity for unactivated platelets. Isoxazolylsulfonamide 34b (DMP 802), a highly selective GPIIb/IIIa antagonist, demonstrated a prolonged duration of action after iv and po dosing and high affinity for resting and activated platelets. The prolonged antiplatelet profile of DMP 802 in dogs and the high affinity of DMP 802 for human platelets may be predictive of clinical utility as a once-daily antiplatelet agent.

Administration, Oral↗

Isoxazoline GPIIb/IIIa antagonists bearing a phosphoramidate.

Isoxazolinylacetamides bearing a phosphoramidate group alpha- to the carboxylate moiety (3) were prepared and evaluated for in vitro antiplatelet efficacy. They were found to bind GPIIb/IIIa with high affinity and were potent antagonists of ADP mediated platelet aggregation.

Animals↗